Sign in

You're signed outSign in or to get full access.

Daniel L. Comas

Director at Veralto
Board

About Daniel L. Comas

Independent director candidate class: II; age 61; on Veralto’s board since 2023. Retired Executive Vice President at Danaher (EVP 2005–2020; CFO 2005–2018) and currently an advisor to Danaher, with deep experience in finance, capital allocation, and M&A; also a director at Fortive and member of its compensation committee . Veralto’s Board is declassifying subject to shareholder approval and maintains strong governance policies including an independent Chair and robust stock ownership and anti-hedging/pledging requirements .

Past Roles

OrganizationRoleTenureCommittees/Impact
Danaher CorporationExecutive Vice PresidentApr 2005–Dec 2020Led corporate development, treasury, finance, and risk management; key architect in Danaher’s M&A program; deep capital allocation and strategy expertise .
Danaher CorporationChief Financial OfficerApr 2005–Dec 2018Oversaw finance and accounting functions; embedded business system discipline; VES cultural fluency carries over to Veralto oversight .
Danaher CorporationAdvisorOngoingAdvisory role; provides continuity of VES principles and M&A insights; potential independence consideration for Veralto governance .

External Roles

OrganizationRoleTenureCommittees
Fortive CorporationDirectorSince Mar 2021Compensation committee member .
Danaher CorporationAdvisorOngoingN/A (advisor, not director) .

Board Governance

  • Director class and term: Class II; director since 2023; standing for election to serve until the 2028 annual meeting .
  • Committee assignments: None at Veralto; not listed on Audit, Compensation, or Nominating and Governance committees .
  • Independence: Not included among directors the Board has affirmatively determined are independent under NYSE standards; independent directors listed exclude Comas .
  • Attendance: Veralto held 7 board meetings in 2024, and all directors attended 100% of board and committee meetings for the period served .
  • Governance environment: Independent Chair; regular executive sessions; annual board/committee self-assessments; anti-overboarding policy; related person transactions reviewed by Nominating & Governance Committee .
  • Governance enhancements on ballot: Declassification of board (Proposal 4A) and elimination of supermajority vote provisions (Proposal 4B) recommended by the Board .

Fixed Compensation

YearFees Earned (Cash) ($)Notes
2024105,000Standard director cash retainer; chair and committee chair roles earn additional cash retainers (Audit $25k; Compensation $20k; Nominating & Governance $15k; Chair $150k), but Comas holds no chair roles .

Performance Compensation

YearStock Awards ($)Option Awards ($)Equity StructureVesting/Distribution
202481,85982,510Director equity awards split between RSUs and stock optionsOptions fully vested at grant; RSUs vest on earlier of 1-year from grant or immediately prior to next annual meeting; RSU shares distributed on death or 7 months after board retirement .
  • Omnibus Plan cap: Aggregate annual limit of $800,000 per non-management director for cash plus equity grant-date fair value .
  • Valuation basis: Stock awards valued at closing price (adjusted for lack of dividends pre-vesting); options valued via Black-Scholes with disclosed assumptions .

Other Directorships & Interlocks

  • Fortive: Board and compensation committee membership; industrial domain adjacency to Veralto’s markets .
  • Danaher ties at Veralto: Several Veralto directors hold or held Danaher directorships (e.g., Linda Filler; John T. Schwieters), indicating network interlocks that may influence governance culture and acquisition oversight frameworks .
  • Related person oversight: Veralto’s Related Person Transactions Policy requires Nominating & Governance Committee review and approval; committee also oversees conflicts and independence .

Expertise & Qualifications

  • Deep credentials in finance, corporate strategy, capital allocation, M&A; accounting, risk management, and human capital management .
  • Segment-relevant exposure: Water quality and product quality & innovation; global/international experience; governmental/legal/regulatory familiarity .

Equity Ownership

HolderBeneficial Ownership (#)Notes
Daniel L. Comas27,302Includes options to acquire 3,595 shares .
Outstanding Director Equity (12/31/2024)Options: 3,595Comas’ aggregate options outstanding; fully vested .
Outstanding Director Equity (12/31/2024)Unvested RSUs: 842Comas’ aggregate RSUs subject to time-based vesting and deferred distribution .
  • Director stock ownership requirements: Non-management directors must beneficially own Veralto shares equal to at least 5x their annual cash retainer within five years; beneficial ownership includes RSUs and certain indirect holdings but excludes unexercised options .
  • Anti-pledging/hedging: Directors prohibited from pledging and hedging Veralto securities (subject to limited grandfathering); options from company plans excepted from derivative prohibition .

Governance Assessment

  • Strengths:

    • Transactional rigor and capital allocation discipline stemming from Danaher EVP/CFO tenure; highly relevant to Veralto’s acquisition-led strategy and VES culture .
    • 2024 board effectiveness signals: 100% attendance across seven meetings; robust board self-assessment; independent Chair; clear committee risk oversight mandates .
    • Alignment tools: Director equity mix and mandatory ownership multiple; anti-hedging/pledging rules; transparent equity vesting mechanics .
  • Concerns/RED FLAGS:

    • Independence: Comas is not listed among independent directors; advisory role at Danaher may raise perceived conflict risks as Veralto continues portfolio actions and M&A; mitigants include formal related-party review policy .
    • Interlocks: Multiple Veralto directors with Danaher ties could concentrate governance network influence; investors should monitor how this affects board challenge culture and acquisition oversight .
  • Compensation program context:

    • Director pay appears standard (cash + equity); no performance-based metrics apply to director grants, aligning with market practice; equity is time-vested (RSUs) and options fully vested at grant, with deferred RSU distribution enhancing long-term orientation .
    • Shareholder sentiment positive: 92% say-on-pay approval in 2024 for executive program; independent consultant (FW Cook) engaged with conflict safeguards .